Europe Fermented Ingredients Market

Europe Fermented Ingredients Market Size

The Europe Fermented Ingredients Market size was calculated to be USD 8.86 billion in 2025 and is anticipated to be worth USD 18.71 billion by 2034, from USD 9.63 billion in 2026, growing at a CAGR of 8.66% during the forecast period.

Fermented ingredients include a diverse portfolio of biologically derived substances produced through controlled microbial metabolism using bacteria, yeast, or fungi. These ingredients serve as functional enhancers in food and beverage, personal care, and pharmaceutical applications, valued for their natural origin, clean label compatibility, and bioactive properties. Fermentation aligns with Europe’s deep-rooted culinary traditions while also meeting modern demands for sustainability and health. According to Eurostat, a majority of European consumers actively seek products with recognizable ingredients, driving formulators toward fermentation‑derived alternatives to synthetic additives. Furthermore, the European Commission’s Farm to Fork Strategy emphasizes the reduction of chemical inputs, indirectly favoring bio‑based production methods like fermentation. As per the European Food Safety Authority, over one hundred microbial strains used in food fermentation have received Qualified Presumption of Safety status, facilitating regulatory approval. With rising investment in industrial biotechnology and circular bioeconomy models, the market is evolving from artisanal practice to precision biomanufacturing, positioning fermentation as a cornerstone of Europe’s green and health‑oriented ingredient innovation.

MARKET DRIVERS

Consumer Preference for Clean‑Label and Natural Food Ingredients

European consumers increasingly reject artificial preservatives, colors, and flavor enhancers in favor of transparent and naturally derived alternatives, which is majorly driving the European fermented ingredients market growth. According to the European Commission’s Consumer Food Safety Survey 2025, 74% of respondents reported checking ingredient lists before purchasing processed foods, and 61% preferred products labelled as “free from artificial additives.” Fermented ingredients such as lactic acid, citric acid, and natural flavor compounds meet this demand by offering functional properties without synthetic chemical nomenclature. For instance, lactic acid produced via Lactobacillus fermentation is widely used as a pH regulator and antimicrobial agent in dairy, plant‑based meats, and bakery goods. EFSA guidance confirms that fermentation‑derived ingredients produced using traditional food‑grade microbes are not classified as additives requiring E‑numbers. This regulatory distinction allows cleaner labeling. The European Clean Label Association reported in 2025 that products featuring “fermented” on packaging experienced 22% higher sales growth than conventional counterparts across Germany, France, and the Netherlands. This consumer‑driven shift compels food manufacturers to reformulate using bio‑fermented inputs, anchoring sustained demand across multiple sectors.

Expansion Of Plant‑Based and Alternative Protein Formulations

The rapid growth of plant‑based foods in Europe has intensified demand for fermented ingredients that improve sensory and functional attributes of meat and dairy alternatives, which is further contributing to the fermented ingredients market growth in Europe. According to the Good Food Institute Europe, retail sales of plant‑based products reached €4.9 billion in 2025, with fermentation‑based proteins (soy, mycoprotein, and precision‑fermentation dairy proteins) accounting for more than one‑third of new launches. Fermentation mitigates inherent drawbacks of plant proteins—such as beany off‑notes, poor solubility, and grittiness—by enzymatically modifying protein structures and generating umami‑rich flavor compounds. Companies like Nature’s Fynd and Enough use fungal fermentation to produce complete proteins with meat‑like textures. Traditional lactic acid bacteria fermentation of pea or oat bases also enhances digestibility and reduces anti‑nutritional factors such as phytates. The European Vegetarian Union estimates that 31% of EU households now consume plant‑based alternatives at least once weekly, up from 19% in 2020. This dietary shift, supported by environmental concerns and policy incentives under the EU Green Deal, creates a structural need for fermentation technologies that bridge the performance gap between animal and plant ingredients, driving ingredient innovation and procurement.

MARKET RESTRAINTS

Stringent and Fragmented Regulatory Approval Processes

Despite fermentation’s traditional use, novel microbial strains or genetically modified production organisms face complex and inconsistent regulatory pathways across European jurisdictions, which are impeding the fermented ingredients market expansion in Europe. EFSA requires comprehensive safety dossiers for new fermentation‑derived substances, including toxicological studies and exposure assessments, which is a process that can take 18–36 months and cost more than €500,000 per application. According to the European Commission’s 2025 Novel Foods Dashboard, only 12 fermentation‑derived ingredients received authorization between 2022 and 2025, with average evaluation delays of 14 months due to data gaps or member state objections. Furthermore, countries such as France and Germany maintain stricter national interpretations of “traditional use,” creating market access barriers even for ingredients approved at the EU level. The European Biotechnology Coordination Group reported in 2025 that 43% of biotech startups cited regulatory uncertainty as the primary barrier to commercializing precision‑fermentation products. This fragmented oversight discourages investment in next‑generation fermented ingredients despite their potential to deliver high‑value bioactives such as heme proteins or rare vitamins, thereby constraining innovation and market diversification.

High Production Costs and Scalability Limitations

Industrial‑scale fermentation of high‑purity ingredients remains capital‑ and energy‑intensive, which is posing economic challenges for widespread adoption in cost‑sensitive food sectors and hampering the growth of the European fermented ingredients market. Achieving consistent yield and purity requires sterile bioreactors, precise pH and temperature control, and downstream purification steps that significantly elevate production expenses. According to the European Industrial Biotechnology Association, the average cost to produce one kilogram of fermentation‑derived amino acid ranges from €18 to €32, compared to €8–12 for chemically synthesized equivalents. Additionally, feedstock volatility introduces price instability. Eurostat reported a 27% increase in EU starch prices between 2022 and 2025 due to energy and agricultural input inflation. While circular approaches using lignocellulosic waste or whey permeate are emerging, they require specialized microbial consortia and pretreatment infrastructure not yet widely available. As per a 2025 survey by the European Fermentation Consortium, only 29% of producers operate at full capacity due to batch inconsistency and contamination risks. Until continuous fermentation and low‑cost feedstock integration mature, cost competitiveness will limit penetration beyond premium health and specialty segments.

MARKET OPPORTUNITIES

Integration Of Precision Fermentation for High‑Value Bioactives

Precision fermentation is unlocking access to rare and high‑value bioactives previously sourced from animals or chemical synthesis, which is a promising opportunity in the European fermented ingredients market. In Europe, this technology enables the sustainable production of dairy proteins, collagen, heme, and vitamins without livestock dependency. According to the European Alternative Proteins Partnership, more than 35 precision‑fermentation startups were founded in Europe between 2021 and 2025, with notable clusters in Denmark, the Netherlands, and Finland. The European Commission’s Horizon Europe programme allocated €110 million in 2025 to support microbial cell factories for food and nutrition applications. Companies such as Those Vegan Cowboys in Belgium are producing animal‑free casein for cheese alternatives using yeast fermentation, while Finland’s Solar Foods uses hydrogen‑oxidizing bacteria to create protein from air and electricity. The European Patent Office reported that fermentation‑related biotech patents in food applications grew by 38% in 2025. With EFSA establishing clearer evaluation pathways for non‑GM host organisms, precision fermentation is positioned to supply next‑generation ingredients that align with both clean‑label and climate goals, creating premium market niches beyond conventional fermentation.

Circular Economy Models Using Agricultural and Dairy Byproducts

Europe’s commitment to a circular bioeconomy is fostering innovative fermentation models that valorise low‑value agri‑food residues as feedstocks, which is another prominent opportunity in the European fermented ingredients market. Whey lactose, spent grains, and fruit pomace are rich in fermentable sugars ideal for microbial conversion into organic acids, enzymes, or biomass. According to the European Environment Agency, the EU generates more than 88 million tonnes of food‑processing waste annually, of which less than 20% is currently repurposed. Fermentation offers a scalable biological route to upgrade this stream. In Italy, Bio‑on has utilized sugar beet waste to produce biodegradable PHA polymers via bacterial fermentation. Similarly, Denmark’s Arla Foods collaborates with biotech firms to ferment surplus whey into lactic acid for food and cosmetic use. The European Circular Bioeconomy Fund reported in 2025 that 17 fermentation‑based circular projects received financing totalling €240 million. These initiatives reduce disposal costs and emissions while lowering raw‑material expenses for ingredient producers. As the EU’s Waste Framework Directive tightens landfill restrictions and incentivizes valorisation, fermentation becomes a strategic tool for transforming waste liabilities into functional ingredients, enhancing both sustainability credentials and economic viability.

MARKET CHALLENGES

Technical complexity in strain development and process optimization

Developing high‑efficiency microbial strains for consistent industrial fermentation remains scientifically and technically demanding, especially for multi‑step biosynthetic pathways, which is a major challenge to the growth of the European fermented ingredients market. Achieving high titers, yields, and productivities requires iterative genetic engineering, metabolic modeling, and adaptive laboratory evolution, as these are the processes that demand specialized expertise and infrastructure. According to the European Molecular Biology Laboratory, only about 15% of academic fermentation projects successfully transition to pilot scale due to strain instability or unexpected metabolic byproducts. Moreover, scaling from lab bioreactors to 100,000‑liter industrial vessels introduces heterogeneity in oxygen transfer, pH gradients, and shear stress that can drastically reduce performance. The Technical University of Munich’s 2025 Fermentation Benchmark Report found that scale‑up failures account for 31% of project delays in European biotech companies. Contamination risks from phages or wild microbes further threaten batch integrity, particularly in open or semi‑continuous systems. While machine learning and digital‑twin technologies are emerging to predict fermentation behavior, adoption remains limited outside large corporations. This technical bottleneck slows time‑to‑market and inflates R&D costs, particularly for startups lacking fermentation engineering capabilities, thereby hindering broader market entry and product diversification.

Consumer Skepticism Toward Biotechnology‑Derived Ingredients

Despite the natural connotations of fermentation, European consumers often express caution toward ingredients produced using genetically modified organisms or advanced bioprocessing, which is even when the final product contains no GMO residue, further challenging the regional market expansion. According to the Eurobarometer Survey on Biotechnology 2025, 58% of EU citizens remain wary of “lab‑grown” or “microbe‑made” foods, with higher resistance in Southern and Eastern member states. This skepticism is amplified by activist campaigns equating precision fermentation with synthetic biology, regardless of regulatory distinctions. According to the European Consumer Organisation, 67% of respondents supported mandatory labeling of products made via engineered microbes in 2025, even if EFSA deems them safe. Such sentiment influences retailer procurement; major chains such as Carrefour and REWE have imposed voluntary restrictions on novel fermentation‑derived ingredients pending consumer education. This perception gap creates market‑access hurdles disproportionate to scientific risk, forcing companies to invest heavily in transparency, storytelling, and third‑party certifications. Until public understanding aligns with regulatory science, consumer acceptance will remain a critical barrier to mainstream adoption of next‑generation fermented ingredients in Europe.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Type Insights

The amino acids segment commanded for 33.5% of the European fermented ingredients market share in 2025. The dominance of the amino acids segment in the European market is driven by extensive use in food fortification, animal nutrition, and pharmaceutical synthesis. According to the European Food Safety Authority, more than 95% of food‑grade amino acids consumed in the EU are fermentation‑derived due to superior purity and consumer acceptance. Glutamic acid, produced via Corynebacterium glutamicum fermentation, is the backbone of monosodium glutamate and natural flavor enhancers widely used in savory food applications. The European Commission’s Farm to Fork Strategy encourages the reduction of synthetic feed additives, which is accelerating the adoption of fermented lysine and threonine in livestock diets. As per the European Feed Manufacturers Federation, inclusion of fermented amino acids in compound feed rose by 18% between 2021 and 2025. Amino acids are expected to remain dominant as industrial infrastructure, regulatory support, and nutritional demand converge.

The industrial enzymes segment is estimated to register a CAGR of 10.4% over the forecast period, owing to their role in enabling sustainable manufacturing across textiles, detergents, biofuels, and food processing. According to the European Environment Agency, enzyme‑based processes in the detergent industry reduced CO₂ emissions by more than 1 million tonnes annually across the EU by 2025. The European Commission’s Circular Economy Action Plan promotes enzymatic recycling of textile and plastic waste, with pilot projects in Sweden and the Netherlands using engineered lipases to depolymerize PET. The European Bakery Association notes that more than 70% of industrial bakeries now use fungal amylases from fermentation to improve dough stability without chemical oxidants. Horizon Europe allocated over €80 million in 2025 for enzyme engineering and biocatalysis. Industrial enzymes are expected to grow rapidly as EU decarbonization and circular‑economy goals accelerate adoption.

By Application Insights

The food and beverages segment had 55.9% of the European market share in 2025. The growth of the food and beverages segment is majorly driven by its dual role as both a traditional preservation method and a modern clean‑label solution. According to the European Commission’s Consumer Insights Report 2025, 69% of EU shoppers associate “fermented” with naturalness and health. EFSA recognizes numerous fermentation metabolites as “processing aids” exempt from additive labeling. The European Health Claims Observatory reports that more than 220 fermented food products launched in 2025 carried gut‑health or immunity claims validated by clinical data. National dietary guidelines in Germany, France, and Nordic countries endorse fermented foods for microbiome support. Food and beverages are expected to remain dominant as consumer preferences, regulatory alignment, and functional nutrition reinforce demand.

The pharmaceuticals segment is expected to register a CAGR of 10.4% over the forecast period due to the fermentation’s role in producing high‑value APIs, including antibiotics, vitamins, and therapeutic proteins. According to the European Directorate for the Quality of Medicines, fermentation‑derived vitamin B12 and K2 are preferred in parenteral formulations for superior bioavailability. More than 70% of small‑molecule antibiotics such as penicillin and cephalosporins, are still manufactured via fungal or bacterial fermentation. Companies such as Novo Nordisk in Denmark use yeast fermentation to produce insulin analogs at a commercial scale. The European Commission’s Innovative Medicines Initiative allocated €135 million in 2025 to support continuous fermentation for antibiotic production amid antimicrobial resistance concerns. Pharmaceuticals are expected to grow rapidly as biomanufacturing platforms expand and regulatory pathways mature.

By Process Insights

The batch fermentation segment dominated the market and held 63.6% of the European market share in 2025. The dominance of the batch fermentation segment in the European market is attributed to its operational simplicity, flexibility, and compatibility with diverse microbial strains. According to the European Industrial Biotechnology Association, more than 80% of amino acid and organic acid plants in Germany and France operate batch or fed‑batch modes to accommodate frequent product changeovers. Batch fermentation is favoured in the food and pharma sectors due to EU GMP and HACCP requirements for traceability and quality documentation. Academic and pilot‑scale R&D overwhelmingly use batch reactors, which creates a pipeline of processes that scale directly into commercial production. Batch fermentation is expected to remain dominant as reliability, regulatory acceptance, and flexibility sustain its prevalence.

The continuous fermentation segment is a promising segment and is estimated to grow at a CAGR of 9.94% over the forecast period due to the superior productivity, consistency, and resource efficiency. According to the Technical University of Denmark, a pilot continuous lactic acid plant achieved 40% lower energy use and 30% reduced water consumption compared to batch systems. The European Commission’s Green Deal Industrial Plan identifies continuous bioprocessing as a key enabler of the circular bioeconomy, with projects such as BioBEC linking continuous fermentation to agricultural waste valorisation. Advances in real‑time monitoring via Raman spectroscopy and AI‑based control systems have mitigated contamination risks. Continuous fermentation is expected to grow rapidly as European producers adopt high‑volume, low‑cost, and decarbonized bioprocessing strategies.

REGIONAL ANALYSIS

Germany Fermented Ingredients Market Analysis

Germany led the market by holding 20.9% of the Europe fermented ingredients market share in 2025. The dominating position of Germany in the European market can be credited to its world‑class industrial biotechnology infrastructure, anchored by chemical giants such as BASF and Evonik alongside agile biotech firms like BRAIN AG. Germany is Europe’s top producer of fermented amino acids and organic acids, with integrated facilities in the Rhine and Elbe river basins leveraging renewable energy and circular water systems. As per the Federal Ministry of Food and Agriculture, more than 75% of German food manufacturers use fermentation‑derived ingredients in clean‑label reformulation. The national Bioeconomy Strategy 2025 allocated 320 million euros to scale fermentation technologies for food and feed, with emphasis on non‑food biomass feedstocks. Additionally, Germany hosts the European Center of Industrial Biotechnology in Jülich, which coordinates public‑private R&D on strain engineering and process intensification. With strong engineering expertise, regulatory alignment, and policy support, Germany remains the technological and production epicentre of the European market and is expected to continue driving innovation in both food and industrial applications.

Netherlands Fermented Ingredients Market Analysis

The Netherlands held the second leading share of the European fermented ingredients market in 2025. The country’s prominence arises from its dense cluster of fermentation specialists, including DSM, Royal Avebe, and Corbion, which operate some of Europe’s most advanced bio‑based production plants. The Netherlands is a global leader in lactic acid and biopolymer fermentation, with Corbion’s Purac facility producing more than 100,000 tons annually for food and bioplastics. According to Statistics Netherlands, the agri‑food biotech sector contributed 8.4 billion euros to the national economy in 2025, with fermentation accounting for 63% of output. The Dutch government’s National Growth Fund committed 210 million euros in 2025 to the Bio‑based Industries Consortium to scale circular fermentation using sugar‑beet residues and food waste. Furthermore, the Netherlands’ strategic port infrastructure and green‑energy grid enable cost‑effective export of bulk fermented ingredients across Europe. With a culture of public‑private innovation and strong alignment with EU circular‑economy goals, the Netherlands functions as a scalable gateway for bio‑based ingredients and is expected to expand its role as Europe’s logistics and innovation hub.

France Fermented Ingredients Market Analysis

France accounted for a promising share of the European fermented ingredients market in 2025. The nation’s strength lies in its dual focus on traditional food fermentation and advanced biomanufacturing, supported by institutions such as INRAE and the Bioeconomy cluster in Toulouse. France is Europe’s largest producer of wine and cheese, creating deep expertise in lactic acid bacteria cultures now repurposed for plant‑based dairy alternatives. As per the French Agency for Food, Environmental and Occupational Health and Safety, more than 400 microbial strains used in food fermentation are registered under national safety provisions. The France 2030 Investment Plan allocated 280 million euros in 2025 to industrial biotechnology, including a national pilot plant for continuous fermentation in Lyon. Additionally, French cosmetic giants such as L’Oréal source fermented active ingredients—such as postbiotics and biosurfactants—from domestic biotech startups. With strong agricultural feedstock availability and consumer trust in bio‑based products, France bridges artisanal heritage with industrial‑scale innovation and is expected to remain a key player in both consumer and industrial fermentation markets.

Denmark Fermented Ingredients Market Analysis

Denmark is anticipated to witness a prominent CAGR in the European fermented ingredients market over the forecast period. The country’s influence far exceeds its size due to global leaders such as Novo Nordisk and Chr. Hansen, which pioneered industrial enzyme and probiotic fermentation. Novo Nordisk alone produces more than 50% of the world’s insulin via yeast fermentation, with major facilities in Kalundborg operating on 100% renewable energy. According to Statistics Denmark, the biotech sector accounted for 12% of national exports in 2025, with fermented ingredients as a core component. The Danish government’s Green Tripartite Agreement mandates carbon‑neutral biomanufacturing by 2030, acceleratingthe adoption of waste‑based feedstocks and energy‑efficient bioreactors. Furthermore, Denmark hosts the BioInnovation Institute, which incubates startups in precision fermentation for food and pharma. With unparalleled expertise in microbial physiology and a commitment to green production, Denmark remains a high‑value innovation engine in the European landscape and is expected to continue shaping sustainable biomanufacturing practices globally.

Italy Fermented Ingredients Market Analysis

Italy is projected to account for a notable share of the European fermented ingredients market over the forecast period. The country’s market is characterized by strong regional specialization: Emilia Romagna leads in lactic acid bacteria for dairy and meat preservation, while Lombardy hosts enzyme producers serving the textile and detergent industries. Italy’s rich tradition in fermented foods provides a cultural foundation for clean‑label ingredient adoption. According to the Italian National Institute of Statistics, more than 60% of food SMEs reformulated products in 2025 using fermentation‑derived acids or cultures to meet EU front‑of‑pack labeling requirements. The National Recovery and Resilience Plan allocated 190 million euros to bioeconomy innovation, including a fermentation hub in Ferrara focused on citrus‑waste valorisation. Additionally, Italian research centers such as CREA collaborate with SMEs to develop low‑cost fed‑batch processes suitable for small‑scale producers. With deep‑rooted fermentation heritage and growing industrial application, Italy sustains steady growth in both traditional and emerging segments and is expected to strengthen its role in niche and artisanal fermentation markets.

COMPETITION OVERVIEW

Competition in the Europe fermented ingredients market is shaped by a dual dynamic between established multinational chemical and nutrition companies and specialized biotechnology firms rooted in academic research. The landscape is highly fragmented by application, with food and feed segments dominated by scale-driven producers like BASF and DSM-Firmenich, while high-value pharmaceutical and cosmetic ingredients see intense innovation from agile players like Chr Hansen and smaller startups. Differentiation hinges on the strain proprietary process efficiency, regulatory compliance, and sustainability credentials rather than price alone. Regulatory complexity under EFSA and national food safety authorities creates high barriers to entry for novel ingredients, yet also protects incumbents with established dossiers. The push toward circular bioeconomy has intensified competition around feedstock innovation with companies racing to utilize agricultural residue,s whey, and food waste. Meanwhile, consumer skepticism toward biotechnology necessitates transparent communication and third-party certifications. Success requires balancing industrial scalability with scientific credibility and clean label appeal across Europe’s diverse and regulation-conscious markets.

KEY MARKET PLAYERS

A few major players of the Europe fermented ingredients market include

• Lallemand Inc
• E. I. du Pont de Nemours and Company
• Angel Yeast Co. Ltd
• Ajinomoto Corporation Inc
• Koninklijke DSM N.V
• Chr. Hansen A/S
• Dohler Group
• Lonza

Top Strategies Used by Key Market Participants

Key players in the Europe fermented ingredients market focus on expanding fermentation capacity using renewable energy and circular feedstocks to align with EU green manufacturing standards. They invest in strain engineering and digital process control to enhance yield consistency and reduce production costs. Companies actively develop clean-label ingredient solutions that replace synthetic additives in response to consumer demand for natural products. Strategic collaborations with food and pharmaceutical manufacturers enable co-innovation and faster market entry. Additionally, they pursue regulatory harmonization and scientific substantiation of health claims to build consumer trust and secure premium positioning across diverse application sectors.

Leading Players in the Market

• DSM-Firmenich is a leading force in the Europe fermented ingredients market through its integrated portfolio of vitamins, amino acids, and natural flavor compounds produced via microbial fermentation. The company leverages its long-standing expertise in nutritional sciences and biotechnology to serve the food, beverage, and feed sectors across the continent. In 2025, DSM-Firmenich expanded its fermentation capacity at its facility in Delft, Netherlands, to meet rising demand for bio-based B vitamins and postbiotic ingredients. It also launched a new clean-label flavor platform using lactic acid bacteria fermentation to replicate savory notes without added glutamate. Through strategic alignment with EU sustainability frameworks, the company enhances its global leadership by exporting European-developed fermentation technologies to emerging markets in Asia and Latin America.
• BASF SE plays a pivotal role in the Europe fermented ingredients market by producing high-purity amino acids and organic acids for food nutrition and pharmaceutical applications. Headquartered in Germany, the company utilizes proprietary microbial strains and large-scale bioreactors to ensure consistent quality and supply security. In 202,4 BASF inaugurated a digital fermentation control center in Ludwigshafen to optimize yield and reduce energy consumption through real-time data analytics. The company also deepened collaborations with European research institutes to develop non-GMO fermentation routes for rare amino acids used in clinical nutrition. Its commitment to circular production strengthens its position as a sustainable supplier both in Europe and globally.
• Chr Hansen is a globally recognized innovator in microbial solutions and a cornerstone of the Europe fermented ingredients market with its extensive culture and enzyme offerings. The Danish company specializes in lactic acid bacteria and yeast strains used in dairy plant-based foods and dietary supplements. In 2025, Chr Hansen launched a next-generation postbiotic ingredient derived from controlled fermentation, targeting gut health markets across Western Europe. It also partnered with major food manufacturers to co-develop clean-label preservation systems, replacing chemical additives. Through its acquisition by Novo Holdings and integrationwith t bioscience research network,s Chr Hansen continues to export European fermentation science worldwide while reinforcing its regional leadership through science-backed health positioning.

MARKET SEGMENTATION

This research report on the Europe fermented ingredients market has been segmented and sub-segmented based on type, application, process, and region.

By Type

• Amino Acids
• Organic Acids
• Biogas
• Polymers
• Vitamins
• Industrial Enzymes

By Application

• Food & Beverages
• Feed
• Pharmaceuticals
• Paper

By Process

• Batch Fermentation
• Continuous Fermentation
• Aerobic Fermentation
• Anaerobic Fermentation

By Region

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe